Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PACLITAXEL vs PALIVIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PACLITAXEL vs PALIVIZUMAB: Safety Overview

Metric PACLITAXEL PALIVIZUMAB
Total FAERS Reports 77,334 11,419
Deaths Reported 12,030 1,248
Death Rate 15.6% 10.9%
Hospitalizations 31,638 6,461
Average Patient Age 60.3 yrs 0.8 yrs
% Female Patients 69.4% 42.2%
FDA Approval Date Apr 10, 2025 N/A
Manufacturer Gland Pharma Limited Swedish Orphan Biovitrum AB (publ)
Route INTRAVENOUS INTRAMUSCULAR
Marketing Status Discontinued Prescription